StatPearls2026EN

StatPearls: Sacubitril-Valsartan

Zusammenfassung

Sacubitril-Valsartan - StatPearls - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. more... The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage Main

Kerninformationen

ein Family Models PubChem BioAssay PubChem Compound PubChem Substance PubMed SNP SRA Structure Taxonomy ToolKit ToolKitAll ToolKitBookgh Search term Search Browse Titles Advanced Help Disclaimer --> NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. StatPea...
t in the class of drugs called angiotensin receptor-neprilysin inhibitors. This drug is approved by the United States Food and Drug Administration for the treatment of chronic heart failure with reduced ejection fraction in patients classified as New York Heart Association class II, III, or ...
adverse effects, and contraindications. Additionally, it reviews the clinical toxicity, pharmacokinetics, and monitoring of sacubitril-valsartan. Understanding the intricate pharmacology of sacubitril-valsartan empowers healthcare professionals to tailor treatment plans to individual patient needs,...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien